2. Academic Validation
  3. Pyridine-2-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents

Pyridine-2-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents

  • Bioorg Med Chem Lett. 2006 Dec 1;16(23):6116-9. doi: 10.1016/j.bmcl.2006.08.105.
Paul S Humphries 1,  Jonathon V Almaden,  Sandra J Barnum,  Thomas J Carlson,  Quyen-Quyen T Do,  James D Fraser,  Mary Hess,  Young H Kim,  Kathleen M Ogilvie,  Shaoxian Sun
Affiliations

Affiliation

  • 1 Department of Diabetes Chemistry, Pfizer Global R&D, 10770 Science Center Drive, San Diego, CA 92121, USA. paul.humphries@pfizer.com
PMID: 16979341 DOI: 10.1016/j.bmcl.2006.08.105
Abstract

A series of novel pyridine-2-propanoic acids was synthesized. A structure-activity relationship study of these compounds led to the identification of potent dual PPARalpha/gamma agonists with varied isoform selectivity. Based on the results of efficacy studies in diabetic (db/db) mice, and the desired pharmacokinetic parameters, compound (S)-13 was selected for further profiling.

Figures